Oseaspre Consultants re-appoints Nitin Datanwala as independent director
- Oseaspre Consultants re-appointed Nitin Hariyantalal Datanwala as independent director
- Term is five years starting August 10, 2026, ending August 9, 2031
- Board approved re-appointment on August 7, 2026, per NRC recommendation
- Shareholder approval required within prescribed timeline
- Company cited inadvertent delay in regulatory filing

*this image is generated using AI for illustrative purposes only.
Oseaspre Consultants has re-appointed Nitin Hariyantalal Datanwala as an independent director for a second five-year term. The appointment takes effect from August 10, 2026, and continues until August 9, 2031.
The Board of Directors approved the move on August 7, 2026, based on the recommendation of the Nomination and Remuneration Committee. The re-appointment is subject to shareholder approval within the prescribed timeline.
Director Profile
Nitin Hariyantalal Datanwala brings over 50 years of experience in corporate laws, secretarial, legal, and financial matters. He is a qualified Chartered Accountant and Company Secretary who has handled finance, taxation, legal, and company secretarial functions in the corporate sector.
The company confirmed that he meets the criteria for independence under SEBI Listing Regulations. He is not related to any other directors of the company and is not debarred from holding office by the Securities and Exchange Board of India or any other authority.
Regulatory Disclosure
The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company cited an inadvertent delay in filing this specific disclosure but assured timely compliance moving forward.
Historical Stock Returns for Oseaspre Consultants
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
How might Nitin Datanwala's extensive legal and financial expertise influence Oseaspre Consultants' compliance strategy and risk management over the next five years?
What are the potential market implications of the company's admission of an inadvertent delay in regulatory disclosure, and how might this affect investor confidence?
Will shareholders likely approve the re-appointment given the recent compliance lapse, or could this trigger increased scrutiny during the general meeting?































